Inactive 8(a) Sole Source (FAR 19.8)

NAMRU SOUTH Parasitology has been awarded grants for surveillance and immunology research of parasitic diseases during FY23. This activity requires the use of next generation sequencing technologies. ... NAMRU SOUTH Parasitology has been awarded grants for surveillance and immunology research of parasitic diseases during FY23. This activity requires the use of next generation sequencing technologies. This procedure will use the Illumina MiSeq sequencer that is currently available at NAMRU-6. The requirement is for the following reagents to be used in the Illumina sequencer: 4 Nextera XT DNA Library Preparation Kit (96 samples) 1 Nextera XT Index Kit v2 Set A (96 indexes, 384 samples) 1 Nextera XT Index Kit v2 Set B (96 indexes, 384 samples) If capable sources are not identified through this notice, then NAMRU SOUTH intends to award a sole source contract under the authority of FAR 13.106-l(b)(i) to GENLAB DEL PERU SAC. This pre-solicitation is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to supply the required goods. Capability statements shall not exceed 5 (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source contract. Local vendor will also be invited to participate. Capability statements are due by 12:00 pm Local Eastern Time on Augutst 16, 2023. Capability statements shall be submitted by e-mail ONLY as a Microsoft Word or Adobe PDF attachment to the following address: luciana.i.encinas.ln@health.mil and Javier.b.gil.ln@health.mil Please use subject line "N44852_PAR237030".